These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38583249)
1. Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance. Liu Z; Yang Z; Ablise M Bioorg Chem; 2024 Jun; 147():107310. PubMed ID: 38583249 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802 [TBL] [Abstract][Full Text] [Related]
3. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells. Yang Z; Liu Z; Ablise M; Maimaiti A; Aihaiti A; Alimujiang Y Molecules; 2023 Nov; 28(23):. PubMed ID: 38067428 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Anti-Cervical Cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives. Yang Z; Liu ZY; Ablise M; Maimaiti A; Mutalipu Z; Alimujiang Y; Aihaiti A Molecules; 2023 Jun; 28(11):. PubMed ID: 37299013 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition. Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129 [TBL] [Abstract][Full Text] [Related]
8. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics. Al-Hamashi AA; Koranne R; Dlamini S; Alqahtani A; Karaj E; Rashid MS; Knoff JR; Dunworth M; Pflum MKH; Casero RA; Perera L; Taylor WR; Tillekeratne LMV Bioorg Chem; 2021 Nov; 116():105297. PubMed ID: 34509798 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents. Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors. Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843 [TBL] [Abstract][Full Text] [Related]
12. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790 [TBL] [Abstract][Full Text] [Related]
13. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity. Mourad AAE; Mourad MAE; Jones PG Drug Des Devel Ther; 2020; 14():3111-3130. PubMed ID: 32848361 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site. Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435 [TBL] [Abstract][Full Text] [Related]
15. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance. Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin. He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S; An B; Li Y; Luo X; Li X; Jia X Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents. Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site. Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]